INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2012
|
Total net assets |
£125.0m |
|
NAV per share |
225.4p |
|
Share price |
192.8p |
|
Total value of unquoted investments |
£20.0m |
|
Total number of portfolio companies |
70 |
|
Cash |
5% NAV |
|
Cash committed and reserved to unquoted investments |
(4)% NAV |
|
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Aptiv Solutions |
6.2 4.6 |
|
Gilead Sciences Celgene Alexion |
4.5 4.1 3.9 |
|
Insulet Biogen Pharmaxis |
3.8 3.6 2.9 |
|
Teva Biomarin |
2.6 2.5 |
|
|
----------- |
|
Total |
38.7 |
|
Geographical Allocation |
% |
|
United States & Canada |
79 |
|
Europe |
10 |
|
Israel Australia |
3 3 |
|
Cash |
5 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
79 |
|
Unquoted |
16 |
|
Cash |
5 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JULY 2012